Radiation therapy and grade II/III oligodendroglial tumors

Caroline Chung; Normand Laperriere

doi:10.2217/cns.15.25

Radiation therapy and grade II/III oligodendroglial tumors

Caroline Chung, Normand Laperriere

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Abstract

Radiotherapy has been a longstanding treatment option for low-grade glioma. Improvements in tumor control and radiation-related toxicity may be attributed to advances in neuroimaging as well as radiotherapy planning and delivery. The discovery of various molecular prognostic factors have aided in patient selection for radiotherapy. These prognostic and predictive factors may also play a key role in determining which patients are likely to benefit most from combined systemic therapy and radiation.

Original language	English (US)
Pages (from-to)	325-332
Number of pages	8
Journal	CNS oncology
Volume	4
Issue number	5
DOIs	https://doi.org/10.2217/cns.15.25
State	Published - 2015
Externally published	Yes

Keywords

IMRT
OARs
astrocytoma
chemotherapy
intensity modulated radiotherapy
low-grade glioma
oligodendroglioma
organs at risk
quality of life
radiation necrosis
radiotherapy
temozolomide

ASJC Scopus subject areas

General Medicine

Access to Document

10.2217/cns.15.25

Cite this

@article{e21679c33157445b8a6bcd4cc440aedc,

title = "Radiation therapy and grade II/III oligodendroglial tumors",

abstract = "Radiotherapy has been a longstanding treatment option for low-grade glioma. Improvements in tumor control and radiation-related toxicity may be attributed to advances in neuroimaging as well as radiotherapy planning and delivery. The discovery of various molecular prognostic factors have aided in patient selection for radiotherapy. These prognostic and predictive factors may also play a key role in determining which patients are likely to benefit most from combined systemic therapy and radiation. ",

keywords = "IMRT, OARs, astrocytoma, chemotherapy, intensity modulated radiotherapy, low-grade glioma, oligodendroglioma, organs at risk, quality of life, radiation necrosis, radiotherapy, temozolomide",

author = "Caroline Chung and Normand Laperriere",

note = "Copyright: This record is sourced from MEDLINE{\textregistered}/PubMed{\textregistered}, a database of the U.S. National Library of Medicine",

year = "2015",

doi = "10.2217/cns.15.25",

language = "English (US)",

volume = "4",

pages = "325--332",

journal = "CNS oncology",

issn = "2045-0915",

publisher = "Future Medicine Ltd.",

number = "5",

}

TY - JOUR

T1 - Radiation therapy and grade II/III oligodendroglial tumors

AU - Chung, Caroline

AU - Laperriere, Normand

N1 - Copyright: This record is sourced from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

PY - 2015

Y1 - 2015

N2 - Radiotherapy has been a longstanding treatment option for low-grade glioma. Improvements in tumor control and radiation-related toxicity may be attributed to advances in neuroimaging as well as radiotherapy planning and delivery. The discovery of various molecular prognostic factors have aided in patient selection for radiotherapy. These prognostic and predictive factors may also play a key role in determining which patients are likely to benefit most from combined systemic therapy and radiation.

AB - Radiotherapy has been a longstanding treatment option for low-grade glioma. Improvements in tumor control and radiation-related toxicity may be attributed to advances in neuroimaging as well as radiotherapy planning and delivery. The discovery of various molecular prognostic factors have aided in patient selection for radiotherapy. These prognostic and predictive factors may also play a key role in determining which patients are likely to benefit most from combined systemic therapy and radiation.

KW - IMRT

KW - OARs

KW - astrocytoma

KW - chemotherapy

KW - intensity modulated radiotherapy

KW - low-grade glioma

KW - oligodendroglioma

KW - organs at risk

KW - quality of life

KW - radiation necrosis

KW - radiotherapy

KW - temozolomide

UR - http://www.scopus.com/inward/record.url?scp=85060903921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060903921&partnerID=8YFLogxK

U2 - 10.2217/cns.15.25

DO - 10.2217/cns.15.25

M3 - Review article

C2 - 26477980

AN - SCOPUS:85060903921

SN - 2045-0915

VL - 4

SP - 325

EP - 332

JO - CNS oncology

JF - CNS oncology

IS - 5

ER -

Radiation therapy and grade II/III oligodendroglial tumors

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this